You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Trump's pharmaceutical tariffs could affect some drugmakers more than others

found 2025 › Jul › 29 (Tue) @ 19:30 UTC

Trump ■■■■
AbbVie ■■
Bristol Myers Squibb ■■
Eli Lilly ■■
Novartis ■■
Roche ■■
TD Cowen ■■
Steve Scala ■■

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.